M1K (p.Met1Lys) variant of CDH1 (Cadherin-1)

M1K (p.Met1Lys) in CDH1 (Cadherin-1) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as pathogenic in the context of CDH1-related diffuse gastric and lobular breast cancer syndrome. The available variant effect predictions contribute to a CATVariant prioritization score of 0.35 / 1. The record also includes structural context.

M1K (p.Met1Lys) variant details